Reply to Suicidal Risk During Antidepressant Treatment
J Clin Psychiatry 2011;72(5):722 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
We would like to thank Dr Baldessarini for his comments on our article.
Dr Baldessarini stated that in our sample of 142,000 patients undergoing treatment with antidepressant drugs, the rate of suicidal behavior is far lower than would be expected in a clinical population of depressed patients and that it is even lower than in the general population. This discrepancy is a consequence of the method applied.